Abstract
We now know that some solid neoplasms, such as breast cancer, contain a subpopulation of cells with stem cell properties. This subpopulation, also known as cancer stem cells (CSC), could be responsible for the malignant transformation and the progression of the disease (Wicha et al. 2006). This hypothesis could be useful in clinical practice, not only explaining a lot of the remaining questions about the disease behavior, solving the frequent failure to conventional therapies, and defining the future therapeutic approach with the development of novel targeted therapies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Al-Hajj M, Wicha MS, Benito-Hernandez A, et al. (2003)Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100:3983–3988
Blau, H. M., Brazelton, T. R., & Weimann, J. M. (2001) The evolving concept of a stem cell: entity or function? Cell 105: 829–841
Bunting KD, Lindahl R, Townsend AJ. (1994). Oxazaphosphorine-specific resistance in human MCF-7 breast carcinoma cell lines expressing transfected rat class 3 aldehyde dehydrogenase. J Biol Chem 269:23197–23203
Charafe-Jauffret E, Ginestier C, Iovino F, et al. (2009) Breast cancer cells lines contain functional cancer stem cells with Metastatic Capacity and a Distinct Molecular signature. Cancer Res 69:1302–1313
Cicalese, A., Bonizzi, G., Pasi, C.E., et al (2009). The tumor suppressor p53 regulates polarity of self-renewing divisions in mammary stem cells. Cell 20:1083–1095
Cobaleda C, Cruz JJ, González-Sarmiento R, Sánchez-García I, Pérez-Losada J (2008). The Emerging Picture of Human Breast Cancer: as a Stem Cell-based Disease. Stem Cell Rev 4:67–79
Dontu G, Abdallah WM, Foley JM, et al. (2003) In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev 17:1253–1270
Ginestier C, Hur MH, Charafe-Jauffret E, et al. (2007) ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 1:555–567
Ginestier C, Liu S, Diebel ME, Korkaya H, Luo M, et al. (2010) CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts. J Clin Invest 120 (2): 485–497
Gonzalez-Sarmiento, R. and Perez-Losada, J. (2008) Breast Cancer as a Stem Cell Disease. Current Stem Cell Research and Therapy 3, 55–65
Harrison H, Farmie G, Brennan KR, Clarke RB. (2010a) Breast Cancer Stem Cells: something out of notching?. Cancer Res 2010; 70 (22): 8973–8976
Harrison H, Farnie, G, Howell SJ, et al. (2010b) Regulation of breast cancer stem cell activity by signalling through the Notch4 receptor. Cancer Res 70 (2): 709–718
Hatsell S, Frost AR. (2007)Hedgehog signaling in mammary gland development and breast cancer. J Mammary Gland Biol Neoplasia 12:163–173
Holst CR, Nuovo GJ, Esteller M, et al. (2003) Methylation of p16(INK4a) promoters occurs in vivo in histologically normal human mammary epithelia. Cancer Res 63: 1596–1601
Kim M, Turnquist H, Jackson J, et al. (2002) The multidrug resistance transporter ABCG2 (breast cancer resistance protein 1) effluxes Hoechst 33342 and is overexpressed in hematopoietic stem cells. Clin Cancer Res 8:22–28
Knoblich JA (2010). Asymmetric cell division: recent developments and their implications for tumour biology. Nat Rev Mol Cell Biol 11: 849–860
Korkaya H and Wicha M. (2009) Her-2, Notch and breast cancer stem cells. Clin Cancer Res 15: 1845–46
Korkaya H, Paulson A, Iovino F, et al. (2008) HER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion. Oncogene27:6120–6130
Li X, Lewis MT, Huang J, et al. (2008) Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. J Natl Cancer Inst 100(9):672
Li Y, Welm B, Podsypanina K, et al. (2003) Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells. Proc Natl Acad Sci USA 100:15853–15858
Liu S and Wicha M. (2010) Targeting breast cancer stem cells. JCO 28; 25: 4006–4012
Liu S, Dontu G, Mantle ID, et al. (2006). Hedgehog signaling and BMI-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Res 66:6063–6071
Liu S, GinestierC, Ou SJ, Clouthier SG, Patel S, et al. (2011) Breast Cancer Stem Cells Are Regulated by Mesenchymal Stem Cells through Cytokine Networks. Cancer Res 7 (2): 814–824
Liu S, Ginestier C, Charafe-Jauffret E, et al. (2008) BRCA1 regulates human mammary stem/progenitor cell fate. Proc Natl Acad Sci USA 105:1680–1685
Magnifico A, Albano L, Campaner S, et al. (2009) Tumor-initiating cells of Her2-positive carcinoma cell lines express the highest oncoprotein levels and are trastuzumab sensitive. Clin Cancer Res 15: 2010–21
Marcato P, Dean CA, Araslanova Ret al. (2011) Aldehyde Dehydrogenase Activity of Breast Cancer Stem Cells is Primarily Due to Isoform ALDH1A3 and Its Expression is Predictive of Metastasis. Stem Cells 1; 29: 32–45
McDermott SP, Wicha M. (2010)Targeting breast cancer stem cells. Mol Oncol 4: 404–419
Mego M, Mani SA and Cristofanilli M. (2010) Molecular mechanisms of metastasis in breast cancer – clinical applications. Nat Rev Clin Oncol 7: 693–701
Morimoto K, Kim S, Tanei T, et al. (2009) Stem cell marker aldehyde dehydrogenase 1-positive breast cancers are characterized by negative estrogen receptor, positive human epidermal growth factor receptor type 2, and high Ki67 expression. Cancer Sci 100: 1062–1068
Nickoloff BJ, Osborne BA, Miele L. (2003) Notch signaling as a therapeutic target in cancer: a new approach to the development of cell fate modifying agents. Oncogene 22:6598–6608
Patel SA, Ndabahaline A, Lim PK, Milton R, Rameshwar P. (2010) Challenges in the development of future for breast cancer stem cells. Breast Cancer 2: 1–11
Pece S,Tosoni D, Confalonieri S, et al (2010). Biological and Molecular Heterogeneity of Breast Cancers Correlates with Their Cancer Stem Cell Content. Cell 140: 62–73
Phillips TM, McBride WH, Pajonk F. (2006) The response of CD24(−/low)/CD44+ breast cancer-initiating cells to radiation. J Natl Cancer Inst 98:1777–1785
Polyak K (2007). Breast cancer stem cells: a case of mistaken identity?. Stem Cell Rev 3 (2):107–9
Ponti D, Costa A, Zaffaroni N, et al. (2005) Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res 65:5506–5511
Prat A, Perou CM (2011). Deconstructing the molecular portraits of breast cancer. Mol Oncol. 5(1):5–23
Resetkova E, Reis-Filho J, Jain R., et al. (2010) Prognostic impact of ALDH1 in breast cancer: a story of stem cells and tumor microenvironment. Breast Cancer Res Treat 123(1):97–108
Russo J, Snider K, Pereira JS, Russo IH (2010). Estrogen induced breast cancer is the result in the disruption of the asymmetric cell division of the stem cell. Horm Mol Biol Clin INvestig 1 (2): 53–65
Russo J, Tay LK, Russo IH (1982). Differentiation of the mammary gland and susceptibility to carcinogenesis. Breast Cancer Research and Treatment 2: 5–73
Saal LH, Gruvberger-Saal SK, Persson C, et al. (2008) Recurrent gross mutations of the PTEN tumor suppressor gene in breast cancers with deficient DSB repair. Nat Genet 40:102–107
Shackleton M, Vaillant F, Simpson KJ, et al. (2006) Generation of a functional mammary gland from a single stem cell. Nature 439:84–88
Stingl J and Caldas C (2007). Molecular heterogeneity of breast carcinomas and the cancer stem cell hypothesis. Nat Rev Cancer 7: 791–799
Stingl J, Eirew P, Ricketson I, et al. (2006) Purification and unique properties of mammary epithelial stem cells. Nature 439:993–997
Tanei T, Morimoto K, Shimazu K, et al. (2009) Association of Breast Cancer Stem Cells Identified by Aldehyde Dehydrogenase 1 Expression with Resistance to Sequential Paclitaxel and Epirubicin-Based Chemotherapy for Breast Cancers. Clin Cancer Res 15(12): 4234–4241
Vaillant F, Asselin-Labat ML, Shackleton M, et al. (2007) The emerging picture of the mouse mammary stem cell. Stem Cell Rev 3: 114–123
Villadsen R, Fridriksdottir AJ, Ronnov-Jessen L, et al. (2007). Evidence for a stem cell hierarchy in the adult human breast. J Cell Biol 177:87–101
Wang W, El-Deiry WS. (2008) Restoration of p53 to limit tumor growth. Curr Opin Oncol 20:90–96
Wicha MS, Liu S, Dontu G (2006). Cancer stem cells: an old idea – a paradigm shift. Cancer Res 66:1883–1890
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Salas, N.R., González, E.G., Amat, C.G. (2012). Breast Cancer Stem Cells. In: Scatena, R., Mordente, A., Giardina, B. (eds) Advances in Cancer Stem Cell Biology. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-0809-3_9
Download citation
DOI: https://doi.org/10.1007/978-1-4614-0809-3_9
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-0808-6
Online ISBN: 978-1-4614-0809-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)